Tp53 disruptions: is there a marker of poor prognosis in chronic lymphoproliferative disorders?
Emanuele Cencini, Alberto Fabbri, Donatella Raspadori, Alessandro Gozzetti, Monica Bocchia
Unit of Hematology, Azienda Ospedaliera Universitaria Senese & University of Siena, Siena, Italy.
Correspondence to: Emanuele Cencini, M.D.,Ph.D.
Unit of Hematology, University Hospital, Viale Bracci - 53100 Siena, Italy
E-mail: cencioema@libero.it
Published online: November 4, 2021.
© The Korean Journal of Hematology. All rights reserved.



e-submission

This Article

Current Issue

ba_link01

SCImago Journal & Country Rank

Indexed/Covered by

Today : 57  /
Total : 368,383